Tonix Pharma (TNXP) Tops Q4 EPS by 46c

Tonix Pharma (NASDAQ: TNXP) reported Q4 EPS of ($0.56), $0.46 better than the analyst estimate of ($1.02).

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• ServiceNow (NOW) PT Raised to $155 at Needham